SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-211269
Filing Date
2022-08-03
Accepted
2022-08-03 16:09:39
Documents
15
Period of Report
2022-08-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d386700d8k.htm   iXBRL 8-K 30975
2 EX-99.1 d386700dex991.htm EX-99.1 7241
7 GRAPHIC g386700g0730064414000.jpg GRAPHIC 3675
  Complete submission text file 0001193125-22-211269.txt   201276

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amgn-20220803.xsd EX-101.SCH 3908
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amgn-20220803_def.xml EX-101.DEF 13282
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE amgn-20220803_lab.xml EX-101.LAB 21864
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amgn-20220803_pre.xml EX-101.PRE 14179
9 EXTRACTED XBRL INSTANCE DOCUMENT d386700d8k_htm.xml XML 5149
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 221132651
SIC: 2836 Biological Products, (No Diagnostic Substances)